Arkolith/Insider Trading/BTTX/Form 4

Heinen Mark

See RemarksBetter Therapeutics, Inc. (BTTX) · full profile →Form 4 · filed Sep 14, 2022
Net Buying
Open-Market Buys
$97K
Open-Market Sells
$0
Net Open-Market Flow
$97K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 13, 2022Buy(P)26K$1.94$51K70K
Sep 12, 2022Buy(P)24K$1.94$46K44K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-031045) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML